These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 21517709)
21. Therapeutic opioids: a ten-year perspective on the complexities and complications of the escalating use, abuse, and nonmedical use of opioids. Manchikanti L; Singh A Pain Physician; 2008 Mar; 11(2 Suppl):S63-88. PubMed ID: 18443641 [TBL] [Abstract][Full Text] [Related]
22. Fentanyl use among street drug users in Toronto, Canada: behavioural dynamics and public health implications. Firestone M; Goldman B; Fischer B Int J Drug Policy; 2009 Jan; 20(1):90-2. PubMed ID: 18508256 [TBL] [Abstract][Full Text] [Related]
23. An iterative model for in vitro laboratory assessment of tamper deterrent formulations. Cone EJ; Giordano J; Weingarten B Drug Alcohol Depend; 2013 Jul; 131(1-2):100-5. PubMed ID: 23332441 [TBL] [Abstract][Full Text] [Related]
24. Active surveillance of abused and misused prescription opioids using poison center data: a pilot study and descriptive comparison. Hughes AA; Bogdan GM; Dart RC Clin Toxicol (Phila); 2007; 45(2):144-51. PubMed ID: 17364631 [TBL] [Abstract][Full Text] [Related]
25. Measuring attractiveness for abuse of prescription opioids. Butler SF; Fernandez KC; Chang A; Benoit C; Morey LC; Black R; Katz N Pain Med; 2010 Jan; 11(1):67-80. PubMed ID: 20002325 [TBL] [Abstract][Full Text] [Related]
26. Strategies to optimize pain management with opioids while minimizing risk of abuse. Brennan MJ; Stanos S PM R; 2010 Jun; 2(6):544-58. PubMed ID: 20630441 [TBL] [Abstract][Full Text] [Related]
27. Use and abuse of opioid analgesics: potential methods to prevent and deter non-medical consumption of prescription opioids. Woolf CJ; Hashmi M Curr Opin Investig Drugs; 2004 Jan; 5(1):61-6. PubMed ID: 14983975 [TBL] [Abstract][Full Text] [Related]
28. Changes in and characteristics of admissions to treatment related to problematic prescription opioid use in Ontario, 2004-2009. Fischer B; Nakamura N; Rush B; Rehm J; Urbanoski K Drug Alcohol Depend; 2010 Jun; 109(1-3):257-60. PubMed ID: 20197216 [TBL] [Abstract][Full Text] [Related]
29. Integrating nine prescription opioid analgesics and/or four signal detection systems to summarize statewide prescription drug abuse in the United States in 2007. Schneider MF; Bailey JE; Cicero TJ; Dart RC; Inciardi JA; Parrino M; Muñoz A Pharmacoepidemiol Drug Saf; 2009 Sep; 18(9):778-90. PubMed ID: 19536784 [TBL] [Abstract][Full Text] [Related]
30. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626 [TBL] [Abstract][Full Text] [Related]
31. Investigation of temporal changes of abuse and misuse of prescription opioids. Spiller H; Bailey JE; Dart RC; Spiller SS J Addict Dis; 2010 Jan; 29(1):78-83. PubMed ID: 20390701 [TBL] [Abstract][Full Text] [Related]
32. Prevalence of diversion and injection of methadone and buprenorphine among clients receiving opioid treatment at community pharmacies in New South Wales, Australia. Winstock AR; Lea T; Sheridan J Int J Drug Policy; 2008 Dec; 19(6):450-8. PubMed ID: 18359216 [TBL] [Abstract][Full Text] [Related]
33. Which indicators can public health authorities use to monitor prescription drug abuse and evaluate the impact of regulatory measures? Controlling High Dosage Buprenorphine abuse. Pauly V; Frauger E; Pradel V; Rouby F; Berbis J; Natali F; Reggio P; Coudert H; Micallef J; Thirion X Drug Alcohol Depend; 2011 Jan; 113(1):29-36. PubMed ID: 20692778 [TBL] [Abstract][Full Text] [Related]
34. Relationship between therapeutic use and abuse of opioid analgesics in rural, suburban, and urban locations in the United States. Cicero TJ; Surratt H; Inciardi JA; Munoz A Pharmacoepidemiol Drug Saf; 2007 Aug; 16(8):827-40. PubMed ID: 17636553 [TBL] [Abstract][Full Text] [Related]
35. Pain, substance use disorders and opioid analgesic prescription patterns in veterans with hepatitis C. Whitehead AJ; Dobscha SK; Morasco BJ; Ruimy S; Bussell C; Hauser P J Pain Symptom Manage; 2008 Jul; 36(1):39-45. PubMed ID: 18358690 [TBL] [Abstract][Full Text] [Related]
36. Controlled substance abuse and illicit drug use in chronic pain patients: An evaluation of multiple variables. Manchikanti L; Cash KA; Damron KS; Manchukonda R; Pampati V; McManus CD Pain Physician; 2006 Jul; 9(3):215-25. PubMed ID: 16886030 [TBL] [Abstract][Full Text] [Related]
37. Psychoactive drug abuse in older adults. Simoni-Wastila L; Yang HK Am J Geriatr Pharmacother; 2006 Dec; 4(4):380-94. PubMed ID: 17296542 [TBL] [Abstract][Full Text] [Related]
38. Profiling the subjective, psychomotor, and physiological effects of a hydrocodone/acetaminophen product in recreational drug users. Zacny JP; Gutierrez S; Bolbolan SA Drug Alcohol Depend; 2005 Jun; 78(3):243-52. PubMed ID: 15893155 [TBL] [Abstract][Full Text] [Related]
39. Therapeutic use, abuse, and nonmedical use of opioids: a ten-year perspective. Manchikanti L; Fellows B; Ailinani H; Pampati V Pain Physician; 2010; 13(5):401-35. PubMed ID: 20859312 [TBL] [Abstract][Full Text] [Related]
40. Update on tamper-resistant drug formulations. Romach MK; Schoedel KA; Sellers EM Drug Alcohol Depend; 2013 Jun; 130(1-3):13-23. PubMed ID: 23415386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]